{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:33:30Z","timestamp":1792740810938,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd001430.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T00:00:00Z","timestamp":1439510400000}}],"reference-count":90,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001430.pub4","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T21:37:05Z","timestamp":1439588225000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Corticosteroids for treating optic neuritis"],"prefix":"10.1002","volume":"2021","author":[{"given":"Robin L","family":"Gal","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research; Tampa Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Swaroop","family":"Vedula","sequence":"additional","affiliation":[{"name":"Johns Hopkins University; Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Beck","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research; Tampa Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,8,14]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD001430.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1136\/jnnp.74.8.1139","article-title":"Corticosteroids do not prevent optic nerve atrophy following optic neuritis","volume":"74","author":"Hickman","year":"2003","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001430.pub4-BIB0002|cit2","first-page":"32","article-title":"Double-blind controlled trial of methylprednisolone treatment for acute optic neuritis: 6-month follow-up with visual evoked potential measurement","volume":"2 Suppl","author":"Jones","year":"1996","journal-title":"Multiple Sclerosis"},{"issue":"1","key":"10.1002\/14651858.CD001430.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.50.1.230","article-title":"Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis","volume":"50","author":"Kapoor","year":"1998","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4103\/0301-4738.33821","article-title":"Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis","volume":"55","author":"Menon","year":"2007","journal-title":"Indian Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD001430.pub4-BIB0005|cit5","first-page":"30","article-title":"Optic neuritis treatment trial: Contrast sensitivity; assessment and results","volume":"15","author":"Tabuchi","year":"1998","journal-title":"Neuro-Ophthalmology Japan"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0021-5155(98)00071-9","article-title":"Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG)","volume":"43","author":"Wakakura","year":"1999","journal-title":"Japanese Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0021-5155(98)00072-0","article-title":"Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG)","volume":"43","author":"Wakakura","year":"1999","journal-title":"Japanese Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/archopht.1995.01100020014004","article-title":"The Optic Neuritis Treatment trial: three-year follow-up results","volume":"113","author":"Beck","year":"1995","journal-title":"Archives of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD001430.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group","volume":"326","author":"Beck","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD001430.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0161-6420(94)31103-1","article-title":"The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial","volume":"101","author":"Beck","year":"1994","journal-title":"Ophthalmology"},{"issue":"24","key":"10.1002\/14651858.CD001430.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199312093292403","article-title":"The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis","volume":"329","author":"Beck","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD001430.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archopht.1993.01090060061023","article-title":"Optic neuritis treatment trial. One year follow-up results","volume":"111","author":"Beck","year":"1993","journal-title":"Archives of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD001430.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0002-9394(03)00862-6","article-title":"Visual function more than 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial","volume":"137","author":"Beck","year":"2004","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD001430.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ajo.2004.06.002","article-title":"Optic Neuritis Treatment Trial: 10-Year Follow-up Results - Reply","volume":"138","author":"Beck","year":"2004","journal-title":"American Journal of Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD001430.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archopht.126.7.994","article-title":"Treatment of acute optic neuritis - A summary of findings from the Optic Neuritis Treatment Trial","volume":"126","author":"Beck","year":"2008","journal-title":"Archives of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0161-6420(13)31589-9","article-title":"Fellow eye abnormalities in acute unilateral optic neuritis - Experience of the Optic Neuritis Treatment Trial","volume":"100","author":"Beck","year":"1993","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD001430.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00041327-199509000-00001","article-title":"The Optic Neuritis Treatment Trial - Putting the results in perspective","volume":"15","author":"Beck","year":"1995","journal-title":"Journal of Neuro-Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD001430.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0161-6420(95)30839-1","article-title":"What we have learned from the Optic Neuritis Treatment Trial","volume":"102","author":"Beck","year":"1995","journal-title":"Ophthalmology"},{"issue":"16","key":"10.1002\/14651858.CD001430.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.1993.03500160080036","article-title":"Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial","volume":"269","author":"Chrousos","year":"1993","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0197-2456(93)90015-6","article-title":"Design, methods, and conduct of the Optic Neuritis Treatment Trial","volume":"14","author":"Cleary","year":"1993","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD001430.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00041327-199703000-00004","article-title":"Visual symptoms after optic neuritis - Results from the Optic Neuritis Treatment Trial","volume":"17","author":"Cleary","year":"1997","journal-title":"Journal of Neuro-Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub4-BIB0022|cit22","first-page":"1017","article-title":"The National Eye Institute Visual Function Questionnaire: experience of the ONTT. The Optic Neuritis Treatment Trial","volume":"41","author":"Cole","year":"2000","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"3","key":"10.1002\/14651858.CD001430.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archophthalmol.2010.16","article-title":"Visual field profile of optic neuritis - A final follow-up report from the Optic Neuritis Treatment Trial from baseline through 15 years","volume":"128","author":"Keltner","year":"2010","journal-title":"Archives of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archopht.1993.01090020085029","article-title":"Baseline visual field profile of optic neuritis - The experience of the Optic Neuritis Treatment Trial","volume":"111","author":"Keltner","year":"1993","journal-title":"Archives of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9394(99)00304-9","article-title":"Comparison of central and peripheral visual field properties in the Optic Neuritis Treatment Trial","volume":"128","author":"Keltner","year":"1999","journal-title":"American Journal of Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD001430.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archopht.1994.01090190094027","article-title":"Visual field profile of optic neuritis. One year follow-up in the Optic Neuritis Treatment Trial","volume":"112","author":"Keltner","year":"1994","journal-title":"Archives of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00041327-200106000-00015","article-title":"The SKILL card test in optic neuritis: experience of the Optic Neuritis Treatment Trial","volume":"21","author":"Long","year":"2001","journal-title":"Journal of Neuro-Ophthalmology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001430.pub4-BIB0028|cit28","first-page":"61","article-title":"Corticosteroids for optic neuritis and subsequent development of multiple sclerosis","volume":"120","author":"Noseworthy","year":"1994","journal-title":"Annals of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD001430.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archopht.121.7.944","article-title":"High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis","volume":"121","author":"Optic Neuritis Study Group","year":"2003","journal-title":"Archives of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD001430.pub4-BIB0030|cit30","first-page":"727","article-title":"Multiple sclerosis risk after optic neuritis: final Optic Neuritis Treatment Trial follow-up","volume":"65","author":"Optic Neuritis Study Group","year":"2008","journal-title":"Archives of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD001430.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/archneur.61.9.1386","article-title":"Neurologic impairment 10 years after optic neuritis","volume":"61","author":"Optic Neuritis Study Group","year":"2004","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/WNL.49.5.1404","article-title":"The 5-year risk of MS after optic neuritis: Experience of the Optic Neuritis Treatment Trial","volume":"49","author":"Optic Neuritis Study Group","year":"1997","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD001430.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2007.08.004","article-title":"Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial","volume":"115","author":"Optic Neuritis Study Group","year":"2008","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1002\/14651858.CD001430.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archopht.1997.01100160715008","article-title":"Visual function 5 years after optic neuritis: Experience of the Optic Neuritis Treatment Trial","volume":"115","author":"Optic Neuritis Study Group","year":"1997","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD001430.pub4-BIB0035|cit35","first-page":"A280","article-title":"One-year results in the Optic Neuritis Treatment Trial","volume":"43","author":"Trobe","year":"1993","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9394(14)75429-7","article-title":"Contrast sensitivity and other vision tests in the Optic Neuritis Treatment Trial","volume":"121","author":"Trobe","year":"1996","journal-title":"American Journal of Ophthalmology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001430.pub4-BIB0037|cit37","first-page":"Abstract no. 7","article-title":"A double-blind randomized study of oral prednisolone versus placebo in patients with acute optic neuritis","volume":"20","author":"Frederiksen","year":"1993","journal-title":"Canadian Journal of Neurological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD001430.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1468-1331.2000.00074.x","article-title":"Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis","volume":"7","author":"Sellebjerg","year":"2000","journal-title":"European Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD001430.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1191\/1352458503ms880sr","article-title":"Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis","volume":"9","author":"Sellebjerg","year":"2003","journal-title":"Multiple Sclerosis"},{"issue":"7","key":"10.1002\/14651858.CD001430.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1212\/WNL.52.7.1479","article-title":"A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis","volume":"52","author":"Sellebjerg","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001430.pub4-BIB0041|cit41","first-page":"381","article-title":"A placebo-controlled treatment trial of oral high-dose methylprednisolone in acute optic neuritis","volume":"4","author":"Sellebjerg","year":"1998","journal-title":"Multiple Sclerosis"},{"issue":"3","key":"10.1002\/14651858.CD001430.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0039-6257(94)90201-1","article-title":"The T\u00fcbingen Study on Optic Neuritis Treatment--a prospective, randomized and controlled trial","volume":"39","author":"Katz","year":"1994","journal-title":"Survey of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub4-BIB0043|cit43","first-page":"490","article-title":"The influence of prednisolone on the course of optic neuritis. Results of a double-blind study","volume":"88","author":"Trauzettel-Klosinski","year":"1991","journal-title":"Fortschritte Der Ophthalmologie"},{"issue":"4","key":"10.1002\/14651858.CD001430.pub4-BIB0044|cit44","first-page":"385","article-title":"The T\u00fcbingen Study on Optic Neuritis Treatment - A prospective, randomized and controlled trial","volume":"8","author":"Trauzettel-Klosinski","year":"1993","journal-title":"Clinical Vision Sciences"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01203696","article-title":"The effect of oral prednisolone on visual evoked potential latencies in acute optic neuritis monitored in a prospective, randomized, controlled study","volume":"91","author":"Trauzettel-Klosinski","year":"1996","journal-title":"Documenta Ophthalmologica"},{"issue":"6","key":"10.1002\/14651858.CD001430.pub4-BIB0046|cit46","first-page":"415","article-title":"The Aulhorn flicker test: possibilities and limits. Its use in optic neuritis for diagnosis, differential diagnosis, monitoring the course of the disease, and assessing the effect of oral prednisolone","volume":"1","author":"Trauzettel-Klosinski","year":"1992","journal-title":"German Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD001430.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.11604\/pamj.2014.17.54.2462","article-title":"The role of magnetic resonance imaging and visual evoked potential in management of optic neuritis","volume":"17","author":"Al-Eajailat","year":"2014","journal-title":"Pan African Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD001430.pub4-BIB0048|cit48","first-page":"227","article-title":"Comparative treatment of acute optic neuritis with \"boluses\" of intravenous methylprednisolone or oral prednisone","volume":"130","author":"Alejandro","year":"1994","journal-title":"Gaceta Medica de Mexico"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub4-BIB0049|cit49","first-page":"372","article-title":"Comparison of stimulation therapy with glucocorticoid therapy in optic nerve inflammation","volume":"29","author":"Beran","year":"1973","journal-title":"Ceskoslovenska Oftalmologie"},{"issue":"9","key":"10.1002\/14651858.CD001430.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.optm.2005.07.003","article-title":"Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management","volume":"76","author":"Bhatti","year":"2005","journal-title":"Optometry"},{"issue":"3","key":"10.1002\/14651858.CD001430.pub4-BIB0051|cit51","first-page":"412","article-title":"Treatment of acute optic neuritis","volume":"96","author":"Bird","year":"1976","journal-title":"Transactions of the Ophthalmological Societies of the United Kingdom"},{"issue":"8","key":"10.1002\/14651858.CD001430.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/jnnp.37.8.869","article-title":"A trial of corticotrophin gelatin injection in acute optic neuritis","volume":"37","author":"Bowden","year":"1974","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD001430.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s004150050454","article-title":"Long-term recovery and fellow eye deterioration after optic neuritis, determined by serial visual evoked potentials","volume":"246","author":"Brusa","year":"1999","journal-title":"Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD001430.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s004150070172","article-title":"Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials","volume":"247","author":"Brusaferri","year":"2000","journal-title":"Journal of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00041327-200406000-00013","article-title":"41st Annual Meeting of the Japanese Neuro-Ophthalmology Society, Kyoto, Japan, December 12-13, 2003","volume":"24","author":"Chuman","year":"2004","journal-title":"Journal of Neuro-Ophthalmology"},{"issue":"6075","key":"10.1002\/14651858.CD001430.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/bmj.1.6075.1495","article-title":"Treatment of optic neuritis by retrobulbar injection of triamcinolone","volume":"1","author":"Gould","year":"1977","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD001430.pub4-BIB0057|cit57","first-page":"30","article-title":"Progress of optic neuritis with and without corticosteroid treatment. Findings in a long-term investigation with static perimetry","volume":"80","author":"Hallermann","year":"1983","journal-title":"Fortschritte der Ophthalmologie"},{"key":"10.1002\/14651858.CD001430.pub4-BIB0058|cit58","unstructured":"Hickman S NOON. Nitric oxide in optic neuritis: A phase I randomised double-blind study of rapid corticosteroid treatment of optic neuritis National Research Register, UK 2002"},{"issue":"3","key":"10.1002\/14651858.CD001430.pub4-BIB0059|cit59","first-page":"126","article-title":"Treatment of optic neuritis with corticosteroids. Discussion at the 10th Meeting of the International Neuro-ophthalmological Society (Freiburg 5 to 9 June 1994)","volume":"205","author":"Kommerell","year":"1994","journal-title":"Klinische Monatsblatter Fur Augenheilkunde"},{"key":"10.1002\/14651858.CD001430.pub4-BIB0060|cit60","first-page":"S23","article-title":"Optic neuritis in multiple sclerosis patients treated with copaxone","volume":"244","author":"Kott","year":"1997","journal-title":"Journal of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD001430.pub4-BIB0061|cit61","first-page":"425","article-title":"Optic neuritis: diagnosis, treatment and follow-up","volume":"125","author":"Midgard","year":"2005","journal-title":"Tidsskrift for Den Norske Laegeforening"},{"key":"10.1002\/14651858.CD001430.pub4-BIB0062|cit62","unstructured":"Midgard R Seland JH Hovdal H Celius EG Eriksen K Jensen D Retraction of article Tidsskrift for den Norske Laegeforening 2005 125 15 2056"},{"issue":"1","key":"10.1002\/14651858.CD001430.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3341\/jkos.2013.54.1.117","article-title":"Additional retrobulbar triamcinolone acetonide injection for retrobulbar optic neuritis patients","volume":"54","author":"Park","year":"2013","journal-title":"Journal of the Korean Ophthalmological Society"},{"issue":"9","key":"10.1002\/14651858.CD001430.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archneur.61.9.1401","article-title":"The natural history of recurrent optic neuritis","volume":"61","author":"Pirko","year":"2004","journal-title":"Archives of Neurology"},{"issue":"7472","key":"10.1002\/14651858.CD001430.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0140-6736(66)92025-3","article-title":"Treatment of acute retrobulbar neuritis with corticotrophin","volume":"2","author":"Rawson","year":"1966","journal-title":"Lancet"},{"issue":"7613","key":"10.1002\/14651858.CD001430.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(69)91469-X","article-title":"Treatment of retrobulbar neuritis with corticotrophin","volume":"294","author":"Rawson","year":"1969","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1212\/01.WNL.0000152873.82631.B3","article-title":"A double-blind randomized trial of IV immunoglobulin treatment in acute optic neuritis","volume":"64","author":"Roed","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub4-BIB0068|cit68","first-page":"387","article-title":"Corticosteroids and acute optic nerve neuritis. A therapeutic method requiring further studies.","volume":"92","author":"Soderstrom","year":"1995","journal-title":"Lakartidningen"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub4-BIB0069|cit69","first-page":"122","article-title":"Treatment of acute optic neuritis with large doses of corticosteroids","volume":"97","author":"Toczolowski","year":"1995","journal-title":"Klinika Oczna"},{"key":"10.1002\/14651858.CD001430.pub4-BIB0070|cit70","unstructured":"Optic neuritis recovery after oral or IV corticosteroids clinicaltrials.gov\/ct2\/show\/NCT01524250"},{"key":"10.1002\/14651858.CD001430.pub4-BIB0071|cit71","unstructured":"A phase IV trial of neuroprotection with ACTH in acute optic neuritis (ACTHAR) clinicaltrials.gov\/ct2\/show\/NCT01838174"},{"key":"10.1002\/14651858.CD001430.pub4-BIB0072|cit72","first-page":"599","volume-title":"Walsh and Hoyt's Neuro-ophthalmology","author":"Beck","year":"1998"},{"issue":"7","key":"10.1002\/14651858.CD001430.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/jnnp-2014-308185","article-title":"Re-evaluating the treatment of acute optic neuritis","volume":"86","author":"Bennett","year":"2015","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/bjo.2005.085399","article-title":"Clinical profile of simultaneous bilateral optic neuritis in adults","volume":"90","author":"la Cruz","year":"2006","journal-title":"British Journal of Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD001430.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archneur.1985.04060070096025","article-title":"Optic neuritis and multiple sclerosis","volume":"42","author":"Ebers","year":"1985","journal-title":"Archives of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD001430.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0161-6420(87)33349-4","article-title":"Deficits in visual function after resolution of optic neuritis","volume":"94","author":"Fleishman","year":"1987","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub4-BIB0077|cit77","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"key":"10.1002\/14651858.CD001430.pub4-BIB0078|cit78","unstructured":"Higgins JPT Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1600-0404.1988.tb03672.x","article-title":"Epidemiology of multiple sclerosis: incidence and prevalence rates in Denmark 1948-64 based on the Danish Multiple Sclerosis Registry","volume":"78","author":"Koch-Henriksen","year":"1988","journal-title":"Acta Neurologica Scandinavica"},{"issue":"7","key":"10.1002\/14651858.CD001430.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archneur.1985.04060070098026","article-title":"Optic neuritis or multiple sclerosis","volume":"42","author":"Kurtzke","year":"1985","journal-title":"Archives of Neurology"},{"issue":"Pt 2","key":"10.1002\/14651858.CD001430.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/brain\/110.2.405","article-title":"Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis","volume":"110","author":"Lightman","year":"1987","journal-title":"Brain"},{"issue":"11","key":"10.1002\/14651858.CD001430.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1001\/archopht.116.11.1496","article-title":"Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ","volume":"116","author":"Mangione","year":"1998","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD001430.pub4-BIB0083|cit83","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.45.2.244","article-title":"Optic neuritis: a population-based study in Olmsted County, Minnesota","volume":"45","author":"Rodriguez","year":"1995","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD001430.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/bjo.70.12.918","article-title":"Estimation of visual function after optic neuritis: a comparison of clinical tests","volume":"70","author":"Sanders","year":"1986","journal-title":"British Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD001430.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0161-6420(88)33220-3","article-title":"Treatment of optic neuritis with intravenous megadose corticosteroids. A consecutive series","volume":"95","author":"Spoor","year":"1988","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD001430.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","article-title":"Optic neuritis","volume":"13","author":"Toosy","year":"2104","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1002\/14651858.CD001430.pub4-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001430","article-title":"Corticosteroids for treating optic neuritis","author":"Gal","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD001430.pub4-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001430.pub3","article-title":"Corticosteroids for treating optic neuritis","author":"Gal","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001430.pub4-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001430.pub2","article-title":"Corticosteroids for treating optic neuritis","author":"Vedula","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001430.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T05:49:26Z","timestamp":1674625766000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001430.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,14]]},"references-count":90,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001430.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,14]]}}}